Gabapentin
Product Images NDC 50090-2794

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-2794). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A line graph depicting mean pain scores over an 8-week period for placebo and Gabapentin 3600 mg/day groups. The x-axis shows weeks from Baseline to Week 8, and the y-axis presents mean pain scores from 0 to 10. The graph distinguishes a 4-week dose titration period followed by a 4-week fixed dose period. Gabapentin group scores decrease steadily, while placebo scores remain relatively stable.*

FDA Label Image

Figure2 (Figure2)

A line graph showing mean pain score over seven weeks comparing placebo with Gabapentin at 1800 mg/day and 2400 mg/day. The x-axis represents weeks divided into a 3-week dose titration period and a 4-week fixed dose period. The y-axis displays mean pain scores from 0 to 10.*

FDA Label Image

Figure3 (Figure3)

A bar graph titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) doses across two studies. Study 1 shows 12% responders for PBO and 29% for GBP 3600 mg. Study 2 shows 14% responders for PBO, 32% for GBP 1800 mg, and 34% for GBP 2400 mg. Statistical significance indicators are noted with p-values less than 0.01 and 0.001.*

FDA Label Image

Figure4 (Figure4)

A scatter plot comparing differences in percentage based on daily dose in milligrams for three studies labeled as Study a, Study b, and Study c. The x-axis represents daily dose in mg ranging from about 600 to 1800, and the y-axis shows difference in percentage from 2% to 22%. Study a is represented by black squares, Study b by gray squares, and Study c by white squares, with respective data points plotted across different dose levels.*

FDA Label Image

Label Image (Lbl500902794)

Gabapentin 300 mg capsule label from A-S Medication Solutions with NDC 50090-2794. The label includes the lot number field, storage instructions to keep at 68 to 77 degrees Fahrenheit, and indicates a package count of 33 unit dose capsules. It also features a QR code and specifies the dosage form as capsules.*

FDA Label Image

Scale (Scale)

A mathematical formula for calculating creatinine clearance (CLCr), involving age in years, weight in kilograms, and serum creatinine in mg/dL, with a multiplication factor of 0.85 for female patients.*

FDA Label Image

Structuralformula (Structuralformula)

Chemical structure of gabapentin showing its cyclohexane ring attached to amino methyl and carboxymethyl functional groups. The diagram depicts the molecular arrangement with labeled chemical fragments CH2NH2 and CH2CO2H.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.